About
Spiderwort Biotechnologies Inc. develops plant-derived cellulose biomaterials and medical-device products for regenerative medicine; its lead product, CelluBridge, is a cellulose-based implant candidate targeting spinal cord injury repair and other tissue-regeneration applications.
Explore Spiderwort Biotechnologies Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.